Joinwith:
 with:   Facebook LinkedIn Email
OR
Join with:
 with:   Facebook LinkedIn Email

THOMAS L. VOGELSONG (TOM)

Advisor


I have always had a passion for advancing technology, solving problems, and improving healthcare. When I became aware of RedCrow and its equity niche-funded approach to connect entrepreneurs pursuing innovative medical technology with investors interested in becoming engaged financially and emotionally with such opportunities, I became an instant enthusiast and asked what I could do to get involved and leverage my experience.

From my days at GE, first in the Global Research Center, and later at GE Medical Systems, I developed new technologies to advance medical, dental and veterinary X-ray, CT, MRI and ultrasound. I then joined smaller, more nimble companies to push technology faster and farther in digital angiography, cardiology and radiology, as well as advanced patient monitors, sensors and bio-fluorescence tagging and imaging.

In order to get closer to customers, I moved into Business Development and created roadmaps for medical technology products to meet customer needs. I headed a start-up which was introducing advanced CMOS image sensors and went through the drill of raising three rounds of capital and subsequently sold the business to Panavision.

There has never been a more opportune time to start a medical technology/healthcare company! Recent advances in sensors, gene therapy, smart phone apps, cloud storage, regenerative medicine, affordable processing horsepower, machine learning, big data, wearables, molecular imaging devices, and networking/connectivity are astounding.

With an aging population and an increased focus on consumer-centric healthcare, outcomes, and efficiency/cost, the potential for an early stage medical/healthcare/biotech company to make a difference in people’s lives and be financially successful is unprecedented.

However, it is extremely difficult in today’s economic environment for promising early stage companies to raise the necessary capital to move forward. Meanwhile, members of RedCrow’s “crowd” of medically-savvy professionals are interested in investing in promising medtech start-ups, using their expertise to help these companies prosper.

I am thrilled to be part of RedCrow and work with a team of talented individuals who are all as passionate as I am about helping companies bring products that benefit society to market. My role at RedCrow is to find emerging medtech companies, assist the Red Crow team in evaluating them for potential listing on our platform, and help them succeed – in RedCrow lingo, discovering and exploring supernovas! How can we connect you with our “crowd” of experts, help you get off the ground and reach the stars?

Want to learn more about investing in Regulation Crowdfunding (Reg CF)? Access our investor educational material here.

Important Disclosures

The www.RedCrow.com website (the “Website” or “Site”) is operated by Red Crow Crowd Inc. (“RedCrow”), which is not a registered broker-dealer or funding portal and is not a member of FINRA. Sections of this website are used by Alira Health Transaction Services (FINRA CRD No. 140203) and is a registered broker-dealer, a member of FINRA | SIPC. Information on all FINRA registered broker-dealers can be found on FINRA’s BrokerCheck. All securities-related activity is conducted by Alira Health Transaction Services, located at 1 Grant St, Framingham, Massachusetts 01702. Neither RedCrow or Alira Health Transaction Services provides investment advice or makes investment recommendations on this website; nothing posted on the Site should be construed as such. No communication, through this website or in any other sections of this website or medium should be construed as a recommendation for any security offered on or off this investment platform.

Alternative investments are speculative, involve a high degree of risk and are not suitable for all investors and you should not invest unless you are able to sustain the risk of loss of your entire investment. Complete loss of principal is possible. Private placements are unregistered securities, considered illiquid and long-term investments. Distributions are not guaranteed. Investing in securities involves risks, and there is always the potential of losing money when you invest in securities.

Content provided is for informational purposes only and is not intended to be an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities or a solicitation of any such offer. Information provided does not take into account an investor’s specific objectives or risk profile. Investment decisions should be made based on your objectives and circumstances and in consultation with your own advisors. Alira Health Transaction Services does not provide tax, legal or accounting advice. Please consult with and rely on a qualified professional.

By accessing this website and any pages thereof, you agree to be bound by the Terms of Use.

Form CRS | Regulation Best Interest | Business Continuity Plan | Privacy Policy | Electronic Delivery Consent.